Synthesis of chitosan-stabilized polymer dispersions, capsules, and chitosan grafting products via miniemulsion

被引:80
作者
Marie, E [1 ]
Landfester, K [1 ]
Antonietti, M [1 ]
机构
[1] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany
关键词
D O I
10.1021/bm015634s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential of chitosan as an emulsion stabilizer is combined with the miniemulsion technique to generate oil droplets, hollow capsules, and latex particles in the diameter range of 100-300 nm carrying a functional biopolymer surface. It turned out that chitosan alone, independent of its molecular weight, is just moderately efficient, which is speculatively attributed to its stiff polysaccharide structure. The addition of biocompatible costabilizers with higher flexibility either to the oil phase or to the water phase, such as Jeffamine or Gluadin (a peptide), eliminates these deficiencies, and very small nanocapsules made of biopolymer hybrids can be obtained. NMR analysis shows that the costabilizer is effectively grafted/cross-linked to the chitosan which makes the miniemulsion route also effective for the modification of hard-to-handle, amphiphilic biopolymers either from the water or from the oil phase.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 43 条
[11]  
Chern CS, 1999, J POLYM SCI POL CHEM, V37, P1489, DOI 10.1002/(SICI)1099-0518(19990515)37:10<1489::AID-POLA11>3.0.CO
[12]  
2-U
[13]   Electrostatic interaction between chitosan-modified latex particles and bovine serum albumin [J].
Chern, CS ;
Lee, CK ;
Ho, CC .
COLLOID AND POLYMER SCIENCE, 1999, 277 (10) :979-985
[14]   A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres [J].
Genta, I ;
Perugini, P ;
Conti, B ;
Pavanetto, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (02) :237-246
[15]   Surface tension and surface dilatational elasticity of associating hydrophobically modified polyacrylamides in aqueous solutions [J].
Kopperud, HBM ;
Hansen, FK .
MACROMOLECULES, 2001, 34 (16) :5635-5643
[16]  
Kumar MNVR, 2001, DRUG DEV IND PHARM, V27, P1
[17]  
Landfester K, 2001, ADV MATER, V13, P765, DOI 10.1002/1521-4095(200105)13:10<765::AID-ADMA765>3.0.CO
[18]  
2-F
[19]  
Landfester K, 1999, MACROMOL RAPID COMM, V20, P81, DOI 10.1002/(SICI)1521-3927(19990201)20:2<81::AID-MARC81>3.0.CO
[20]  
2-G